Rogier Rooswinkel
Board member
Rogier is a general Partner at Forbion. He currently serves as a board member for Amphista, Tessellate, Pheon, Loqus23, Granite and various stealth companies. Previously, Rogier was a board director of Achilles ($ACHL) and an observer at Replimune ($REPL), Enterprise, Prilenia, Nerre and Kandy.
Rogier joined Forbion in 2013. Prior to joining Forbion, Rogier worked as a post-doc at the Netherlands Cancer Institute (NKI), division of immunology. During his studies, Rogier was active as an independent website designer and founded an IT-company.
In 2013 he received his PhD degree Cum Laude from the University of Amsterdam for the work he performed at the NKI. Before that, he received a Master’s degree in Oncology at the VU university of Amsterdam.